D.E. Shaw & Co’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

D.E. Shaw & Co’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,500	Closed	-$797K	–	3683
2016 Q2	$797K	Sell	7,500 -6,500	-46%	-$755K	﹤0.01%	2549
2016 Q1	$1.6M	Buy	14,000 +8,600	+159%	+$1.01M	﹤0.01%	2033
2015 Q4	$769K	Hold	5,400	–	–	﹤0.01%	2826
2015 Q3	$485K	Buy	+5,400	New	+$570K	﹤0.01%	3078

D.E. Shaw & Co's CBPO Position: Q2 2021 in Review

D.E. Shaw & Co sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 21,714 shares — an estimated $2.57M sold.

D.E. Shaw & Co first reported a position in CBPO in Q2 2014 and held it in 28 quarters. The position peaked at $17.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

D.E. Shaw & Co reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
D.E. Shaw & Co sold 21,714 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $2.57M.
D.E. Shaw & Co first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 28 quarters.
D.E. Shaw & Co's China Biologic Products Holdings, Inc. position peaked at $17.8M in Q2 2018.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.